Attorney General Marty Jackley says South Dakota will receive $419,000 from a multistate settlement with a drug company.
Pfizer has agreed to pay $35 million to resolve allegations by 42 states that a subsidiary illegally marketed an organ transplant drug for unapproved uses.
Jackley says the misleading claims put consumers' health at risk.
Authorities say Wyeth Pharmaceuticals, which Pfizer bought in 2009, trained sales representatives to encourage doctors to prescribe Rapamune for uses other than preventing rejection of transplanted kidneys.
Rapamune was approved in 1999 for use in kidney transplant patients. It's illegal to promote drugs for uses not cleared by the Food and Drug Administration.
Pfizer says the alleged activity occurred before it acquired Wyeth. The company didn't admit any wrongdoing or liability as part of the settlement.
Most Popular Today
Sony Cancels 'The Interview' Dec. 25 Release
New Manager Named For South Dakota State Fair
- 3.Gas & Energy
Sioux Falls Average Gas Price Among The Lowest In U.S.
- 4.Retail & Restaurants
December 18 Is 'Free Shipping Day'
Top Theater Chains Cancel 'The Interview' Showings
- 6.Health Care
Third Profile by Sanford Store Opens In Sioux Falls
- 7.Meetings & Events, High School
HS Basketball To Fill Pentagon
SDN Communications To Buy Sioux Valley Wireless
Sturgis Officials Planning For 2015 Rally Traffic
- 10.Gas & Energy
SD Gas Prices At Five-Year Low